Gross Margin - InnoCare Pharma Ltd (SSE:688428) - Alpha Spread

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 11.33 CNY -2.16% Market Closed
Market Cap: 9.6B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

Gross Margin
InnoCare Pharma Ltd

77.1%
Current
90%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
77.1%
=
Gross Profit
482m
/
Revenue
625.4m

Gross Margin Across Competitors

Country CN
Market Cap 9.6B CNY
Gross Margin
77%
Country US
Market Cap 341.7B USD
Gross Margin
67%
Country US
Market Cap 181.2B USD
Gross Margin
63%
Country US
Market Cap 127.2B USD
Gross Margin
87%
Country US
Market Cap 120B USD
Gross Margin
86%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country US
Market Cap 104.6B USD
Gross Margin
77%
Country AU
Market Cap 141.9B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38.5B USD
Gross Margin
97%
Country US
Market Cap 35.1B USD
Gross Margin
87%

Profitability Report

View the profitability report to see the full profitability analysis for InnoCare Pharma Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
77.1%
=
Gross Profit
482m
/
Revenue
625.4m
What is the Gross Margin of InnoCare Pharma Ltd?

Based on InnoCare Pharma Ltd's most recent financial statements, the company has Gross Margin of 77.1%.